UNSPSC 85266301: Diagnosis of non-neuropathic heredofamilial amyloidosis

This classification denotes the group of activities that yields a diagnosis of Non-neuropathic heredofamilial amyloidosis. Non-neuropathic heredofamilial amyloidosisis listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code E85. 0

UNSPSC 85266301 Diagnosis of non-neuropathic heredofamilial amyloidosis (Commodity) shows minimal alignment between the code's nominal scope and the recent state and local opportunities tagged under it. The three recent solicitations—a diagnostic imaging PACS system implementation from San Mateo County, special education contracted services from Birdville Independent School District in Texas, and temporary health professional staffing services from Santa Clara County Health System—address imaging infrastructure, school support services, and clinical staffing, respectively. None involve diagnosis of heredofamilial amyloidosis or specialized genetic or metabolic disease assessment. The code appears to have been applied incorrectly to these opportunities, suggesting either tagging error or that the code is used in this jurisdiction taxonomy for broader diagnostic or health services procurement rather than the narrow inherited metabolic condition the UNSPSC name implies.

The issuing bodies span county health systems and school districts across California and Texas, with no clear pattern of repeat activity under this code. Without additional recent opportunities that genuinely address amyloidosis diagnosis—such as laboratory testing contracts, genetic screening services, or diagnostic equipment procurement tied to metabolic disease—the code shows little relevant recent activity for business development targeting state and local procurement in this specialty area. Firms focused on amyloidosis diagnostics, genetic testing, or related medical services should monitor whether this code continues to be used for unrelated health services procurement or whether future solicitations reflect the code's intended scope.